Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Edition  2010: Volume 15/ Issue 28 Article 5
Back to Table of Contents

Eurosurveillance, Volume 15, Issue 28, 15 July 2010
Call for papers for a special issue on Chagas disease in Europe

Citation style for this article: Call for papers for a special issue on Chagas disease in Europe. Euro Surveill. 2010;15(28):pii=19618. Available online:

Eurosurveillance invites authors to submit papers for a special issue on Chagas disease (American trypanosomiasis) in Europe.

The disease, historically limited to endemic countries in Latin America, has spread globally in the past decades due to increased worldwide migration and is emerging as an important public health problem also in Europe. Transmission in Europe does not occur by vectors, but through blood transfusion, transplantation, or from mother to child. While the numbers of cases in European countries are still comparatively small, the challenge lies in finding a practicable way of identifying blood and organs donations from donors infected with Trypanosoma cruzi, as well as in treating chronic and congenital cases.

The aim of this special issue is to provide a comprehensive source of scientific information on Chagas disease from a European point of view, identifying the extent of the problem in Europe and possible responses, that will stimulate and guide public health interventions. We invite interested scientists to share their findings and submit original papers for peer-review and possible publication.
Topics of interest include but are not limited to:

  • Surveillance reports illustrating the presence and extent of Chagas disease in different European countries;
  • Reports describing already implemented public health measures and discussing their value;
  • Studies on screening, detection, diagnosis or management of Chagas disease undertaken for example in individual hospitals or in particular risk groups;
  • Other research activities around the topic.

A general review will present the background of the disease, pathogen, endemic areas, ways of transmission, available diagnostics and treatment. Individual articles would focus on specific aspects without repeating the introductive part.

The submission deadline is 30 November 2010. If you would like to submit an article or ask for more information, please contact: 

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.